import React from 'react'

export default function ExpertNetwork() {
  return (
    <div className="container mx-auto max-w-4xl px-4 py-8">
      <h1 className="text-3xl font-bold mb-8">Expert Network</h1>
      <p className="text-2xl font-bold mb-8">International Group of Investigators</p>
      
      <div className="space-y-8">
        <section>
          <h2 className="text-xl font-semibold mb-4 text-primary">CO-IMPACT 1</h2>
          <p className="mb-4">Impact of PSMA PET CT/MRI at first diagnosis on outcomes in unfavourable intermediate- and high-risk prostate cancer.</p>
          <h3 className="font-medium mb-2">Principal Investigators (PIs):</h3>
          <ul className="list-disc pl-6 space-y-2">
            <li>Dr. Simon K.B. Spohn (Department of Radiation Oncology, Medical Center – University of Freiburg, Freiburg, Germany, Email: simon.spohn@uniklinik-freiburg.de)</li>
            <li>Dr. Marco Vogel (Department of Radiation Oncology, Technical University Munich, Munich, Germany, Email: marco.vogel@tum.de)</li>
            <li>Dr. Stephanie A. Kroeze (Department of Radiation Oncology, Hospital Aarau, Aarau, Switzerland, Email: stephanie.kroeze@ksa.ch)</li>
            <li>Dr. Giulia Marvaso (Dipartimeno di Oncologia ed Onco-ematologia presso Università degli Studi di Milano, Milano, Italy, Email: Giulia.Marvaso@ieo.it)</li>
          </ul>
        </section>

        <section>
          <h2 className="text-xl font-semibold mb-4 text-primary">CO-IMPACT 2</h2>
          <p className="mb-4">Impact of PSMA PET CT/MR imaging for salvage radiotherapy guidance in prostate cancer patients with recurrent or persistent PSA after primary prostatectomy.</p>
          <h3 className="font-medium mb-2">Principal Investigators (PIs):</h3>
          <ul className="list-disc pl-6 space-y-2">
            <li>Dr. Constantinos Zamboglou (German Oncology Center, Limassol, Cyprus, Email: constantinos.zamboglou@uniklinik-freiburg.de, Constantinos.Zamboglou@goc.com.cy)</li>
            <li>Dr. Nina-Sophie Schmidt-Hegemann (Department of Radiation Oncology, University Munich (LMU), Munich, Germany, Email: Nina-Sophie.Hegemann@med.uni-muenchen.de)</li>
            <li>Dr. Shankar Siva (Department of Radiation Oncology, Peter MacCallum Cancer Center, Melbourne, Australia, Email: Shankar.Siva@petermac.org)</li>
            <li>Dr. Mohamed Shelan (Department of Radiation Oncology, University of Bern, Bern, Switzerland, Email: Mohamed.Shelan@insel.ch)</li>
          </ul>
        </section>

        <section>
          <h2 className="text-xl font-semibold mb-4 text-primary">CO-IMPACT 3</h2>
          <p className="mb-4">Impact of PSMA PET CT/MR imaging in prostate cancer patients with recurrent PSA after primary radiotherapy.</p>
          <h3 className="font-medium mb-2">Principal Investigators (PIs):</h3>
          <ul className="list-disc pl-6 space-y-2">
            <li>Dr. Vedang Murthy (Department of Radiation Oncology, Tata Memorial Centre, India, Email: vmurthy@actrec.gov.in)</li>
            <li>Dr. Amar U. Kishan (Department of Radiation Oncology, UCLA, Los Angeles, USA, Email: AUKishan@mednet.ucla.edu)</li>
            <li>Dr. Tobias Hoelscher (Department of Radiation Oncology, University of Dresden, Dresden, Germany, Email: Tobias.Hoelscher@uniklinikum-dresden.de)</li>
            <li>Dr. Jan Peeken (Department of Radiation Oncology, Technical University Munich, Munich, Germany, Email: jan.peeken@tum.de)</li>
          </ul>
        </section>

        <section>
          <h2 className="text-xl font-semibold mb-4 text-primary">CO-IMPACT 4</h2>
          <p className="mb-4">Impact of PSMA PET CT/MR imaging in castration-resistant prostate cancer patients with radiotherapy due to oligoprogressive disease.</p>
          <h3 className="font-medium mb-2">Principal Investigators (PIs):</h3>
          <ul className="list-disc pl-6 space-y-2">
            <li>Dr. Matthias Guckenberger (Department of Radiation Oncology, University of Zürich, Switzerland, Email: Matthias.Guckenberger@usz.ch)</li>
            <li>Dr. Thomas Zilli (IOSI - Oncology Institute of Southern Switzerland, EOC, Switzerland, Email: Thomas.Zilli@eoc.ch)</li>
            <li>Dr. Ken Herrmann (Essen University Hospital, Germany, Email: ken.herrmann@uk-essen.de)</li>
            <li>Dr. S. Gillessen (IOSI - Oncology Institute of Southern Switzerland, EOC, Switzerland, Email: silke.gillessen.sommer@usi.ch)</li>
          </ul>
        </section>
      </div>
    </div>
  )
} 